Potential Role of Thymosin-1 Adjuvant Therapy for Glioblastoma
Figure 1
Analysis of tumor burden in rats treated with vehicle (control), BCNU (4.4 mg/kg), or BCNU (4.4 mg/kg)+Talpha1 (45 mg/kg). (a) depicts results obtained 17 days after tumor cell implantation. (b) depicts results obtained 21 days after tumor cell implantation. Each dot represents an individual rat case. Closed circles on the 0 line indicate cures. The horizontal bars correspond to the group mean score. Intergroup statistical comparisons demonstrated significantly lower tumor burdens in BCNU-treated relative to control , and between Talpha1 and control or BCNU-treated rats .
